Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Fufeng Group is a leading international bio-fermentation products manufacturer and a major global producer of monosodium glutamate (MSG) and xanthan gum. The company leverages advanced fermentation technology to produce a wide range of products including amino acids, starch sweeteners, and corn refined products for the food, pharmaceutical, and animal nutrition industries. Fufeng is a key supplier of pharmaceutical-grade amino acids such as threonine, valine, and isoleucine, which are essential for various healthcare applications. Headquartered in China and listed on the Hong Kong Stock Exchange, the company operates multiple large-scale production facilities and maintains a significant global market share in bio-based additives and ingredients.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Fufeng Group.